Skip to main content

Table 2 Relation between demographic data and adherence pattern in asthmatic patients already on therapy (n = 110)

From: Drug-related factors affecting medication adherence among Egyptian asthma patients

Variables

Good

Intermediate

Poor

Total

P value

Age/year

43.82 ± 13.501

42.61 ± 13.05

37.56 ± 15.84

41.86 ± 14.06

0.082

Gender

    

0.295

 Males

12 (26.7%)

9 (23.7%)

11 (40.7%)

32 (29.1%)

 Females

33 (73.3%)

29 (76.3%)

16 (59.3%)

78 (70.9%)

Residence

    

0.742

 Rural

19 (42.2%)

13 (34.2%)

11 (40.7%)

43 (39.1%)

 Urban

26 (57.8%)

25 (65.8%)

16 (59.3%)

67 (60.9%)

Educational level

    

0.563

 Illiterate

24 (53.3%)

20 (52.6%)

11 (40.7%)

55 (50%)

 Primary

6 (13.3%)

8 (21.1%)

4 (14.8%)

18 (16.4%)

 Secondary

14 (31.1%)

9 (23.7%)

9 (33.3%)

32 (29.1%)

 Graduate

0 (0.0%)

1 (2.6%)

1 (3.7%)

2 (1.8%)

 Postgraduate

1 (2.2%)

0 (0.0%)

2 (7.4%)

3 (2.7%)

Socioeconomic

    

0.05

 Low

0 (0.0%)

2 (5.3%)

2 (7.4%)

4 (3.6%)

 Middle

45 (100%)

36 (94.7%)

23 (85.2%)

104 (94.5%)

 High

0 (0.0%)

0 (0.0%)

2 (7.4%)

2 (1.8%)

Smoking status

    

0.289

 Non

42 (93.3%)

34 (89.5%)

21 (77.8%)

97 (88.2%)

 Ex-smoker

3 (6.7%)

3 (7.9%)

3 (11.1%)

9 (8.2%)

 Stop smoking

0 (0.0%)

1 (2.6%)

2 (7.4%)

3 (2.7%)

 Current smoker

0 (0.0%)

0 (0.0%)

1 (3.7%)

1 (0.9%)

Smoking index

    

0.797

 Mild

1 (50%)

0 (0.0%)

2(40%)

3 (37.5%)

 Moderate

0 (0.0%)

0 (0.0%)

1 (20%)

1 (12.5%)

 Heavy

1 (50%)

1 (100%)

2 (40%)

4 (50%)

Degree of asthma

    

0.082

 Intermittent

32 (45.7%)

8 (21.1%)

21 (36.2%)

61 (36.7%)

 Mild persistent

4 (5.7%)

9 (23.7%)

10 (17.2%)

23 (13.9%)

 Moderate persistent

25 (35.7%)

15 (39.5%)

21 (36.2%)

61 (36.7%)

 Severe persistent

9 (12.9%)

6 (15.8%)

6 (10.3%)

21 (12.7%)

 Duration of disease

14.49 ± 9.36

11.74 ± 8.45

10.83 ± 10.32

12.64 ± 10

0.097

No. of emergency visit/last year

    

0.231

 1 visits

35 (77.8%)

34 (89.5%)

19 (70.4%)

88 (80%)

 2-4 visits

7 (15.6%)

4 (10.5%)

7 (25.9%)

18 (16.4%)

 > 4 visits

3 (6.7%)

0 (0.0%)

1 (3.7%)

4 (3.6%)

No. comorbidities

27 (32.53%)

31 (37.34%)

25(30.13%)

 

0.153

 1 comorbidities

11 (40.74%)

9 (33.33%)

7 (25.93%)

83 (75.45%)

 ≥ 2 comorbidities

   

27 (24.55%)